Capturing colorectal cancer inter‐tumor heterogeneity in patient‐derived xenograft (PDX) models

Patient‐derived xenograft (PDX) models have become an important asset in translational cancer research. However, to provide a robust preclinical platform, PDXs need to accommodate the tumor heterogeneity that is observed in patients. Colorectal cancer (CRC) can be stratified into four consensus mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasetyanti, Pramudita R., van Hooff, Sander R., van Herwaarden, Tessa, de Vries, Nathalie, Kalloe, Kieshen, Rodermond, Hans, van Leersum, Ronald, de Jong, Joan H., Franitza, Marek, Nürnberg, Peter, Todaro, Matilde, Stassi, Giorgio, Medema, Jan Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Tumor Markers and Signatures
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587871/
https://www.ncbi.nlm.nih.gov/pubmed/30151914
http://dx.doi.org/10.1002/ijc.31767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587871/
https://www.ncbi.nlm.nih.gov/pubmed/30151914
http://dx.doi.org/10.1002/ijc.31767

Ejemplares similares